99mTc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical

A technology of radiopharmaceuticals and amino acids, which can be used in radioactive carriers, in vivo radioactive preparations, peptide/protein components, etc., and can solve problems such as no treatment methods.

Active Publication Date: 2011-04-13
MCW RES FOUND INC
View PDF3 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although Tc-99 can be used in nuclear medicine imaging diagnostic methods, it is not used in any therapeutic methods

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 99mTc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical
  • 99mTc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical
  • 99mTc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0145] HPLC Method 1. At room temperature and a flow rate of 1.0ml / min, a Jupiter C 18 column( Aperture, 250×4.6 mm, Phenomenex). 90% buffer A (water with 0.1% trifluoroacetic acid, v / v) and 10% buffer B (acetonitrile with 0.1% trifluoroacetic acid, v / v) were run for 5 minutes for baseline, then for 35 minutes to 10 Linear gradient of % Buffer A and 90% Buffer B.

[0146] HPLC method 2. At room temperature and a flow rate of 1.0ml / min, Jupiter C 18 column( Aperture, 250×4.6mm). Baseline with 90% Buffer A (phosphate buffer, pH 6.7) and 10% Buffer B (acetonitrile) for 5 minutes, followed by a linear gradient to 10% Buffer A and 90% Buffer B over 30 minutes . Radioactivity levels in the HPLC eluate were monitored by gamma counting at an energy window of 140 ± 15 keV.

[0147] Radiolabeling of Duramycin. After HYNIC modification with 99m Tc labeled Duramycin. Specifically, HYNIC-coupled duramycin was synthesized by reacting succinimidyl 6-hydrazinonicotinic acid acet...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to view more

Abstract

With only 19 amino acids, Duramycin is the smallest known polypeptide that has a defined 3-dimmensional binding structure. Duramycin binds Phosphatidylethanolamine (PtdE) at a 1:1 ratio with high affinity and exclusive specificity. As an abundant binding target, PtdE is a major phospholipid and accounts for about 20 % of the phospholipid content in mammalian cellular membranes. PtdE is externalized to the surface of apoptotic cells, and also becomes accessible in necrotic cells due to compromised plasma membrane integrity. Given the unique physicochemical properties of Duramycin and the availability of PtdE in acute cell death, the goal of this study is to develop and evaluate 99mTc-HYNIC-Duramycin as a novel molecular probe for imaging PtdE. 99mTc-HYNIC-Duramycin is a low-molecular weight, fast-clearing radiopharmaceutical that detects apoptosis / necrosis by binding to PtdE. The goal was to quantify the uptake of 99mTc-HYNIC-Duramycin in the area-at-risk after myocardial ischemia and reperfusion, and to determine the window of detection.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to US Patent Provisional Application No. 61 / 068,764, filed March 10,2008. [0003] Statement on Government Concerns [0004] none. Background of the invention [0005] Non-invasive imaging of acute cell death, including apoptosis and necrosis, has important implications in assessing degenerative disease and monitoring tumor therapy. To obtain better and earlier images, there must be a continuous effort to discover and develop uptake mechanisms and molecular probes that offer improved binding, pharmacokinetic and biodistribution properties. [0006] Technetium (technetium)-99m( 99m Tc) is a gamma-ray-emitting isotope used in radioisotope medical detection, eg, as a radiotracer detectable in vivo as a medical device. 99m Tc is well suited for this role as it readily emits detectable 140keV gamma rays. 99m The half-life of gamma rays emitted by Tc is 6.1 hours, which means that about 15...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K51/04
CPCA61K51/0474A61K51/088A61K38/04A61K38/10A61K38/03
Inventor M·赵
Owner MCW RES FOUND INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap